Sjoerd Klarenbeek
0000-0002-1891-1940
Publication & Citation Trends
Publications
0 total
C-terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.
Cited by 1
Semantic Scholar
The C-terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.
Cited by 1
Semantic Scholar
Abstract 6624: MYC promotes lobuloalveologenesis and mammary tumorigenesis in male mice
Cited by 0
Semantic Scholar
Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors OA
Cited by 17
Semantic Scholar
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer OA
Cited by 19
Semantic Scholar
Abstract LB_B04: Deciphering FGFR3-TACC3 oncogenic fusions
Cited by 0
Semantic Scholar
Abstract 3488: Truncated FGFR2 - a clinically actionable oncogene in multiple cancers
Cited by 0
Semantic Scholar
Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development. OA
Cited by 9
Semantic Scholar
Research Topics
Fibroblast Growth Factor Research
(58)
Cancer Cells and Metastasis
(41)
Eosinophilic Disorders and Syndromes
(23)
Cancer Genomics and Diagnostics
(22)
HER2/EGFR in Cancer Research
(18)
Affiliations
Utrecht University
Dutch Cancer Society
Academic Medical Center
The Netherlands Cancer Institute
University Medical Center Utrecht